Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration

Background. Most patients with metastatic prostate cancer are endocrinologically treated with LHRH agonist, but finally castration-refractory and hormone-refractory cancers occur. Serum testosterone levels get low to “the castration level” by LHRH agonists but may not get low enough against castrati...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Zaitsu, Masayoshi, Yamanoi, Mariko, Mikami, Koji, Takeshima, Yuta, Okamoto, Naohiko, Imao, Sadao, Tonooka, Akiko, Takeuchi, Takumi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi Publishing Corporation 2012
Konular:
Clinical Study
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3130489/
https://ncbi.nlm.nih.gov/pubmed/21754927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/979154
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller